Identical twins Nancy and Margo are thriving after benefiting from a pioneering medical treatment while still in the womb. The procedure, part of a world-first trial, addressed twin-to-twin transfusion syndrome (TTTS), a rare and dangerous condition affecting identical twins.
A Life-Threatening Diagnosis
TTTS occurs when blood vessels shared between twins in the placenta develop abnormally. This can lead to one twin receiving too much blood and amniotic fluid, while the other receives too little. The condition places a significant strain on the hearts of both babies and can be fatal if left untreated.
Innovative In-Utero Intervention
The new approach, described as non-invasive, aims to identify TTTS earlier and improve outcomes for affected families. Scans revealed that the treatment successfully rebalanced the blood flow between Nancy and Margo. Although other complications arose during the pregnancy, the procedure significantly improved the twins' condition. Margo, who had insufficient fluid, was in a better position, and the strain on Nancy's heart eased.
Healthy Birth and Promising Future
Born at nearly 34 weeks, Nancy weighed 3 lbs 7 oz, and Margo weighed 3 lbs 3 oz. Both twins were healthy at birth, with Margo not being as small as initially feared. Now, the sisters are preparing to start primary school, described by their mother as "funny, smart, energetic little girls that just fit right in with their age group."
The charity Twins Trust, which supported the study, highlighted the potential impact of this new treatment. "Any procedure that is non-invasive and can potentially identify TTTS earlier and improve outcomes for our families with this life-threatening condition could be a turning point," said Helen Peck, head of healthcare engagement and research.